Transcarent to Acquire Accolade in $621M Deal – Health M&A
What You Should Know:
– Transcarent, a health and care platform, announced today that it will acquire Accolade (NASDAQ: ACCD), a leader in health advocacy and primary care, for $7.03 per share in cash, representing…
Continue Reading